2022
DOI: 10.1590/1807-3107bor-2022.vol36.0019
|View full text |Cite
|
Sign up to set email alerts
|

ALDH1 expression and potential clinical implications in chronic inflammatory periapical lesions

Abstract: Aldehyde dehydrogenase 1 (ALDH-1) is a marker of stem cells in a variety of diseases, but its role in individuals with chronic inflammatory periapical lesions remains unknown. The aim of this study was to investigate the presence of cells with a stem cell profile based on the immunoexpression of ALDH-1 in periapical granulomas (PGs) and radicular cysts (RCs). A total of 51 cases of periapical lesions (25 PGs and 26 RCs) were subjected to immunohistochemical study. The anti-ALDH-1 antibody was applied using the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 29 publications
(58 reference statements)
0
5
0
Order By: Relevance
“…In the natural pathology of CAP, the tissue at the site of inflammation has the ability to recruit stem cells (Farias et al, 2022), but endogenous stem cells alone are not sufficient to support tissue repair. Mesenchymal stem cells (MSCs) are widely used in tissue engineering (Xing et al, 2019).…”
Section: Mesenchymal Stem Cellsmentioning
confidence: 99%
“…In the natural pathology of CAP, the tissue at the site of inflammation has the ability to recruit stem cells (Farias et al, 2022), but endogenous stem cells alone are not sufficient to support tissue repair. Mesenchymal stem cells (MSCs) are widely used in tissue engineering (Xing et al, 2019).…”
Section: Mesenchymal Stem Cellsmentioning
confidence: 99%
“…The presence of these phenotypes to ALDH1+ cells were registered in other studies ( 14 , 22 ), which have been associated with a better prognosis or simply considered as stem cells ( 23 ). In the present study, we presume that the positive stromal cells are antigen-presenting cells (APCs), including dendritic cells.…”
Section: Discussionmentioning
confidence: 57%
“…The vast majority of studies (24 out of 29) reported experiments on FFPE tissue samples ( Table S3 ), two studies included both fresh-frozen and FFPE samples [ 6 , 39 ], one study reviewed only fresh-frozen samples [ 42 ], and in vitro analysis of human odontogenic lesion-derived cells was performed in two studies [ 43 , 47 ]. A minority of studies (10 out of 29) documented the microscopic diagnosis of included odontogenic entities, either by providing a detailed microscopic description [ 6 , 11 , 12 , 29 , 35 ] or by mentioning an appropriate reference [ 13 , 32 , 36 , 37 , 39 ], e.g., the WHO 2017 [ 1 ] or 2005 [ 51 ] editions for odontogenic tumors and cysts.…”
Section: Resultsmentioning
confidence: 99%
“…One of the studies used a monoclonal antibody against the CD44H standard form and a polyclonal antibody against the CD44V3 isoform, with the same results [ 50 ]. Immunohistochemical experiments on FFPE tissue samples also revealed staining of c-Myc in the epithelium of RC [ 45 ], of CD73 and CD105 in the cystic capsule [ 11 ], and of ALDH1 in both epithelial and mesenchymal cells of RC [ 35 ]. Moreover, flow cytometric analysis confirmed CD44, CD73, and CD105 expression in mesenchymal cells isolated from human RCs (HRCMCs), and also showed CD13, CD29, and CD90 expression in those cells at similar levels with dental pulp stem cells (DPSCs), except for CD105, which was underexpressed in HRCMCs compared to DPSCs [ 43 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation